3T Biosciences
Blood & Organ Banks · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Haskins Way Fl 5, South San Francisc...Website
www.3tbiosciences.comRevenue
$8 MillionIndustry
About 3T Biosciences
3T Biosciences is an immunotherapy company focused on developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases. They aim to address a significant challenge in targeted biotherapeutics by identifying novel targets for cancer treatment. Their innovative approach positions them at the forefront of transforming cancer care for broad patient populations. The company is dedicated to advancing immunotherapy as a key component in the future of cancer treatment.Explore more
3T Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to 3T Biosciences
Compare insights from companies similar to 3T Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
3T Biosciences Tech Stack
A closer look at the technologies used by 3T Biosciences
Top Blood & Organ Banks Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 3T Biosciences
Sign Up For FreeTo access detailed company insights
3T Biosciences is an immunotherapy company focused on developing next-generation therapies for the treatment of solid tumors and other immune-mediated diseases. They aim to address a significant challenge in targeted biotherapeutics by identifying novel targets for cancer treatment. Their innovative approach positions them at the forefront of trans... Read More
